Back
Open Access

Post-activity quiz and discussion

Session: Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population
Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Speaker: Doctor P. MORRIS (Charleston, US)
Sponsored by National Lipid Association
Event: ESC CONGRESS 2019

Congress Session

0

About the speaker

Doctor Pamela MORRIS

Medical University of South Carolina, Charleston (United States of America)
2 presentations
0 follower

4 more presentations in this session

Clinical implications for patients at persistent ASCVD risk

Speaker: Doctor J. Saseen (Aurora, US)

Access
Slides
Video
0
Thumbnail

Clinical trial updates

Speaker: Doctor C. Ballantyne (Houston, US)

Access
Slides
Video
0
Thumbnail

The future of lipid management: new therapies for LDL-C lowering

Speaker: Doctor H. Bays (Louisville, US)

Access
Slides
Video
0
Thumbnail

Questions and answers / Panel discussion

Access
Slides
Video
0
Thumbnail

Access the full session

Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population

Speakers: Doctor P. MORRIS, Doctor J. Saseen, Doctor C. Ballantyne, Doctor H. Bays
Access
0
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

This platform is supported by

logo Novo Nordisk